Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023
Agency IQ
JULY 28, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94
40 
Let's personalize your content